S-EPMC4652458 - TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial - OmicsDI

Unknown

Dataset Information

TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial

ABSTRACT:

SUBMITTER: Nemunaitis J

PROVIDER: S-EPMC4652458 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature